Latest news with #medical
Al Jazeera
2 hours ago
- Politics
- Al Jazeera
Gaza child in hospital with Israeli bullet protruding from her skull
Gaza child in hospital with Israeli bullet protruding from her skull NewsFeed A child in Gaza has survived being struck in the head by a bullet fired from an Israeli drone. Video shows the young girl being treated by doctors with a bullet lodged in the back of her skull. Video Duration 00 minutes 54 seconds 00:54 Video Duration 01 minutes 22 seconds 01:22 Video Duration 02 minutes 54 seconds 02:54 Video Duration 01 minutes 30 seconds 01:30 Video Duration 01 minutes 26 seconds 01:26 Video Duration 01 minutes 13 seconds 01:13 Video Duration 00 minutes 47 seconds 00:47
The Independent
19 hours ago
- Health
- The Independent
Physio who accessed patient's personal data to visit her home is struck off
A medical professional who used a patient's personal data to visit her home with a gift while working as a vaccinator has been struck off the register. Josep Bofill Blanch, who was a registered physiotherapist employed by NHS Grampian in north-east Scotland, met the woman and gave her an injection when she attended his vaccination centre on May 7 2021. He then found and messaged her on Facebook to ask if her arm was sore, before visiting her rural address the following day with a bottle of Kombucha tea as a gift when there was 'no clinical justification' for him to do so, according to a Health and Care Professions Council (HCPC) tribunal panel. Computer logs showed Mr Blanch had used a national vaccination database system to view the woman's record, which included her address, on three separate occasions after she had received her injection and left the centre. The panel found Mr Blanch's behaviour had breached professional boundaries and amounted to conduct done in the pursuit of a future sexual relationship. The physiotherapist had started working as a vaccinator on Fridays in the Macduff Vaccination Centre in Aberdeenshire from February 2021. Mr Blanch said he found the woman on Facebook after administering her injection as he knew her first and last name and used her social media photograph to identify her. When interviewed about the Facebook message she received from Mr Blanch, the woman said: 'I thought it was strange and ignored it. You can find anyone online, but I thought it was inappropriate.' The woman did not respond to his message. Describing his appearance at her home on May 8 2021, she said: 'I live very rural and isolated. In amongst barns. I did not see anyone there. 'I parked up after taking the dog to the vet. I never heard him approach but he appeared when I took the dog out the car. 'It was distressing for the children … it was quite a shock.' Interviewed about the incident, Mr Blanch said he felt the woman had been upset during her vaccination and he wanted to visit her to ask her how she was feeling, as it was the custom in his culture. He later provided an alternative explanation for the visit by saying that he wanted to make friends. A witness said Mr Blanch had told her he knew the rough area where the woman lived from their conversations at the vaccination clinic, so he had drove there and asked a neighbour who pointed him in the right direction. The HCPC panel found Mr Blanch's explanation for knowing and finding the woman's address was 'implausible' and 'unbelievable', and said that if he was genuinely concerned about the woman it 'should have been escalated through appropriate channels at work'. 'In all the circumstances, the panel determined that the explanations provided by (Mr Blanch) at the local interview stage were inconsistent and his conduct in attending (the woman's) address with a gift was highly inappropriate,' the panel said. Mr Blanch was suspended by NHS Grampian on May 14 2021 and resigned on August 3 of that year, before an investigation was completed. He did not tell the HCPC about the suspension, with the healthcare body only being notified after receiving a referral from NHS Grampian almost five months later on October 13, and tried to seek other employment in the profession. The panel found Mr Blanch's conduct was dishonest 'by the standards of an ordinary decent person'. It concluded all the facts proved in the case fell far below the standards required in the profession and amounted to misconduct. Mr Blanch 'showed limited insight' into his own misconduct and provided no evidence of provided any meaningful reflection or steps taken to address the concerns, meaning there was a 'real risk' he could repeat his actions in the future, the panel said. His behaviour amounted to 'persistent and intensified unwanted attention' towards the woman that 'placed his needs in the pursuit of a future, sexual relationship above the wellbeing and privacy of a service user', it added. The panel made an order to strike Mr Blanch's name from the register after determining his fitness to practise was impaired. An NHS Grampian spokesperson said: 'We note the decision of the HCP tribunal service. This individual was suspended in May 2021 and left the organisation in August 2021.'
National Post
a day ago
- Business
- National Post
Canopy Growth Appoints Miles Worne as Managing Director of European Markets
Appointment reinforces Canopy Growth's focus on accelerating growth in Europe and delivering on its Global Medical strategy Article content SMITHS FALLS, Ontario — Canopy Growth Corporation ('Canopy Growth' or the 'Company') (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the appointment of Miles Worne as Managing Director of European Markets, effective August 11, 2025. Article content Article content Mr. Worne will be responsible for leading the Company's commercial operations and go-to-market execution across the region. His appointment reflects a strategic investment in Europe, where Canopy Growth aims to deepen its presence in established medical markets and build the capabilities needed to support long-term expansion as new opportunities emerge. Article content 'Europe represents one of the most compelling long-term growth opportunities for Canopy Growth,' said Luc Mongeau, Chief Executive Officer. 'With a strong commercial background and deep experience in the cannabis sector navigating complex markets, Miles is well-positioned to help scale our presence in the region and support the delivery of our global medical strategy.' Article content Mr. Worne is an experienced commercial leader with over 20 years of global experience across the cannabis, healthcare, and consumer sectors. Most recently, he served as President of Curaleaf International, where he led the expansion of the company's European medical cannabis operations. His background includes senior leadership roles in Europe, North America, and Asia at Glanbia Performance Nutrition and SlimFast International. Mr. Worne brings a strong track record of driving growth, building teams, and scaling businesses in regulated markets. Article content 'I'm pleased to join Canopy Growth during a time of developing momentum in Europe,' said Miles Worne. 'Canopy Growth is uniquely positioned with high-quality supply, trusted medical brands, and a growing presence in priority markets. I look forward to working with the team to build on this foundation and deliver meaningful growth in the region.' Article content The Company's European operations are supported by European Union Good Manufacturing Practices (EU-GMP) certified supply from its Kincardine, Ontario facility, enhanced processing and distribution capabilities at its St. Leon-Rot facility in Germany, and a global supply chain infrastructure designed to meet the needs of patients and partners across the region. Article content About Canopy Growth Article content Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives. Article content Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia. Article content Article content Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA, LLC ('Canopy USA'). Canopy USA's portfolio includes ownership of Acreage Holdings, Inc., a vertically integrated multi‑state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness, LLC, The Cima Group, LLC, and Mountain High Products, LLC, a leading North American edibles brand, and majority ownership of Lemurian, Inc., a California-based producer of high-quality cannabis extracts and clean vape technology. Article content At Canopy Growth, we're shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we're paving the way for a better understanding of all that cannabis can offer. Article content Article content Article content Article content Contacts Article content
BBC News
a day ago
- Sport
- BBC News
'Dijksteel arrives to complete Buddies switch'
Cork City striker Malik Dijksteel has arrived in Scotland for a medical after a fee was agreed for the 24-year-old to allow his immediate transfer after he signed a pre-contract agreement to join St Mirren in December. (Daily Record), externalRead Thursday's Scottish Gossip in full.
Yahoo
a day ago
- Business
- Yahoo
Perennial Holdings, Lujiazui Administrative Bureau and Lujiazui Group Sign Strategic Partnership to Establish Shanghai's First Wholly Foreign-Owned Tertiary General Hospital
SINGAPORE, July 31, 2025 /PRNewswire/ -- Perennial Holdings Private Limited ("Perennial Holdings") is pleased to announce that it has entered into a strategic partnership agreement with the Lujiazui Administrative Bureau of the China (Shanghai) Pilot Free Trade Zone ("Lujiazui Administrative Bureau") and Shanghai Lujiazui (Group) Co., Ltd., ("Lujiazui Group"), under which Perennial Holdings will incorporate a foreign medical investment company in the Lujiazui District to establish Shanghai's first wholly foreign-owned tertiary general hospital ("Perennial General Hospital Shanghai"). Perennial General Hospital Shanghai is expected to be established at a total investment cost of RMB500 million with a planned capacity of 500 beds. The hospital will be built according to international standards, integrating advanced medical equipment and technology, as well as global service standards. It will also encompass an outstanding team of medical experts from China and abroad to deliver patient-centred care. Aside from general medical areas such as internal medicine, surgery and health screening, the hospital will house centres of excellence with specialisations including orthopedics, oncology, cardiovascular diseases and otolaryngology. Designed with a garden-style healing environment and personalised care, the hospital is committed to delivering a safe, efficient and comfortable patient experience. The hospital will also serve as a premier platform for global medical exchange, fostering collaboration and sharing of clinical expertise. Mr Pua Seck Guan, Executive Chairman and Chief Executive Officer of Perennial Holdings, said, "We are delighted to partner the Lujiazui Administrative Bureau and Lujiazui Group, bringing together our collective expertise and reaffirming our long-term confidence in China's healthcare market. Shanghai is a dynamic international financial and trade hub as well as a global tourism destination, attracting business elites, talents and high-net-worth tourists from all over the world. Along with the city's highly cosmopolitan local residents, Shanghai is witnessing a burgeoning demand for premium and personalised medical services." Mr Pua added, "The Lujiazui District stands as the most globalised and comprehensive business ecosystem within Shanghai's financial centre. Located 30 kilometres from the Pudong International Airport and accessible via an eight-minute magnetic levitation train ride, the District enjoys strong international connectivity. The Perennial General Hospital Shanghai will leverage its strategic location to serve both local residents and expatriates in the city, and introduce innovative medical treatments and packages for high-net-worth international clients to support the growth of Shanghai's medical tourism sector. Through the hospital, we are committed to establishing an exceptional healthcare hub with global reach, contributing to the city's development as an international consumption centre." A spokesperson from the Lujiazui Administrative Bureau, said: "We warmly welcome Perennial Holdings' introduction of international medical resources to the Lujiazui District, which will significantly contribute to our vision of building a world-class financial city. The Lujiazui District is a hub for nearly 50,000 domestic and international enterprises and 500,000 professionals. It has a distinctly outward-facing economy, with a highly integrated and developed industrial and urban ecosystem, making it an ideal city for living and working. Striving to become a key hub for Shanghai's "Five Centres" initiative and a leading development zone in the Pudong New Area, the District is focused on promoting regional economic development and optimising its business and living environments. This new hospital will be instrumental in developing Lujiazui District's "Big Health" industry ecosystem and elevation of its reputation worldwide." A spokesperson from the Lujiazui Group, said: "Drawing from Perennial Holdings' international expertise in the healthcare sector, the Perennial General Hospital Shanghai will greatly benefit from Pudong New Area's conducive policies to introduce advanced international medical treatments and healthcare management to meet the diverse healthcare needs of residents across the Yangtze River Delta region and offer world-class medical services catered to expatriates. This hospital will be pivotal in advancing Lujiazui District's infrastructure, fostering integrated innovation across healthcare, finance and technology, while supporting the synergistic growth of Shanghai's international financial centre and the broader health industry." As an integrated healthcare and real estate company, Perennial Holdings has five healthcare-centric transit-oriented developments ("TODs") typically integrating medical care, eldercare and hospitality components, connected to high-speed railway stations located in Tianjin, Kunming, Chengdu, Xi'an and Chongqing. Currently, the company owns, manages and operates over 25,000 beds in medical and eldercare facilities, comprising about 16,000 operational beds and over 9,000 beds in the pipeline, across 15 cities in China and Singapore. For media enquiries, please contact: Ms Tong Ka-Pin Chief Corporate Officer DID: (65) 6602 6828 HP : (65) 9862 2435 Email: Ms Crystal Tan Assistant Manager, Investor Relations, Corporate Communications & Marketing DID: (65) 6602 0994 HP : (65) 8128 8268 Email: About Perennial Holdings Private Limited ( Perennial Holdings Private Limited ("Perennial Holdings") is an established integrated healthcare and real estate company headquartered in Singapore. The company owns, manages and operates over 25,000 beds in medical and eldercare facilities, comprising about 16,000 operational beds and over 9,000 beds in the pipeline, across 15 cities in China and Singapore. In China, Perennial Holdings owns and operates the country's first private integrated healthcare ecosystem, which combines a unique medical platform centred on partnerships with doctors and one of the largest private eldercare platforms in the country. Its comprehensive medical care facilities encompass general, rehabilitation, specialist and nursing hospitals, while its eldercare facilities include independent living, assisted living, nursing homes and dementia care. In Singapore, the Company will operate the nation's first private assisted living development and is set to launch the country's first-of-its-kind private integrated rehabilitation and traditional Chinese medicine sanctuary. Perennial Holdings' quality real estate portfolio spans over 84 million square feet in total gross floor area across China, Singapore, Malaysia and Indonesia. The company focuses strategically on large-scale transit-oriented developments ("TODs"), serving as enablers of its healthcare portfolio, and landmark integrated developments. It has six TODs in China which are connected to high-speed railway ("HSR") stations, of which five located in Tianjin, Chengdu, Kunming, Xi'an and Chongqing, are healthcare-centric, and one commercial-centric HSR TOD is in Hangzhou. View original content to download multimedia: SOURCE Perennial Holdings Private Limited Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
